Tag: Michael Vodicka

7 Essential Tips To Succeed With Cannabis Stocks

Posted on by The INO.com Team

Analysis originally distributed on February 22, 2017 By: Michael Vodicka of Cannabis Stock Trades

Interest in cannabis stocks is spiking in 2017.

This trend isn’t just on display with higher trading volume. It is also validated by the most powerful search engine in the world: Google.

When I typed marijuana stocks into Google Trends this chart below came up.

As you can see, search volume for marijuana stocks spiked to an all-time high during the election and once again early this year.

Marijuana Stocks Google Search Results
Chart courtesy of Google Trends

This is a bullish signal for cannabis stocks.

It tells me additional capital will be flowing into the sector from investors eager to profit from legal cannabis. Continue reading "7 Essential Tips To Succeed With Cannabis Stocks" →

3 Cannabis Stocks Ready To Hit A New 52-Week High

Posted on by The INO.com Team

Analysis originally distributed on Feburary 15, 2017 By: Michael Vodicka of Cannabis Stock Trades

I was a derivatives trader for a billion-dollar trading firm at the Chicago Board of Trade for three years in my late twenties.

It was a crazy job. My job was to make huge bets all day long in highly volatile markets.

The key to this position was the chart.

I would hunt for specific formations on the chart, looking for stocks, bonds, commodities, or currencies ready to breakout into a new high or breakdown into a new low.

Once I found the right setup I would slap on million-dollar trades looking to “scalp” the market for a quick profit.

BIG NEWS!!! We're now accepting new Cannabis Stock Trades Premium members!

This is the insanity of short-term trading and why I am now an investment advisor. You have to be nuts to gamble like that all day. Investing is a thousand times easier than trading.

However, as an investment advisor and financial writer, my background in trading is a weapon.

It helps me see things in the market that a lot of other advisors and investors miss. Continue reading "3 Cannabis Stocks Ready To Hit A New 52-Week High" →

North American Cannabis Stock Index Already Up 5% In 2017

Posted on by The INO.com Team

Analysis originally distributed on February 8, 2017 By: Michael Vodicka of Cannabis Stock Trades

Cannabis stocks are off to a good start in 2017.

After gaining 4.2% in January, the MJIC North American Cannabis Stock Index is now up more than 5% on the year.

Although that’s a great return for any ‘normal’ stock index, it might not jump off the page after cannabis stocks delivered big returns in 2016.

However, looking below the surface, you’ll see plenty of cannabis stocks have been burning up the charts in 2017.

Canadian cannabis stocks have been leading the pack.

Canopy Growth Corp (TSX:WEED), Canada’s largest medical cannabis company, is up 25% in 2017.

That bullish movement has been driven by a steady stream of good news. Continue reading "North American Cannabis Stock Index Already Up 5% In 2017" →

Canada's Only Legal Monopoly Is Up 360% In 12 Months

Posted on by The INO.com Team

Analysis originally distributed on February 1, 2017 By: Michael Vodicka of Cannabis Stock Trades

If you want to invest in a legal monopoly – I’ve got just the cannabis stock for you.

This early industry leader is the only Canadian cannabis stock with a license to produce and sell cannabis in Alberta – Canada’s fast-growing and fourth-largest province with a population of 4.1 million.

It just reported record first-quarter results, with revenue up 151% from just last quarter.

And finally, it’s in the early stages of building an 800,000 square foot, state of the art, cultivation center.

When you add it all together, this early industry leader is one of the most exciting stocks in the cannabis sector.

Aurora Cannabis Inc. (NASDAQ:ACBFF) is the second largest medical cannabis company in Canada with a market cap of $650 million.

Aurora currently operates a 55,200 square foot cultivation facility in Mountain View County. Continue reading "Canada's Only Legal Monopoly Is Up 360% In 12 Months" →

Analysts Predicting a 58% Gain for this Leading Cannabis Biotech

Posted on by The INO.com Team

Analysis originally distributed on January 25, 2017 By: Michael Vodicka of Cannabis Stock Trades

The cannabis industry is loaded with dozens of biotechs.

For example, if you take a look at the North American cannabis sector, you’ll see that the field is littered with biotechs such as Axim Biotechnologies (OTC:AXIM), Cara Therapeutics (Nasdaq:CARA) and Insys Therapeutics (Nasdaq:INSY).

These companies are aggressively searching for a cannabis-based medicine to treat some of the worst diseases plaguing humankind, including cancer, epilepsy, and HIV.

It’s obvious the cannabis industry sees a big opportunity in pharmaceuticals and is investing billions in research and development to cash in.

On the one hand, it’s great that investors have so many cannabis biotechs to choose from.

On the other, investing in biotech stocks is already one of the hardest sectors to pick winners and losers.

It’s even harder in the cannabis sector.

Some of these early cannabis biotechs will go on to make billions on blockbuster drugs and deliver market-crushing returns to shareholders.

Others will crumble and file for bankruptcy.

Today, I want to share my #1 cannabis biotech stock that I believe is ready to soar in 2017. Continue reading "Analysts Predicting a 58% Gain for this Leading Cannabis Biotech" →